Ordering
Available Variants5 g
CHA.92080-5g
Price
€43.84
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 g | CHA.92080-5g | €43.84 |
analytical standard
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C12H14N2O2 |
|---|---|
| CAS Number | 125-33-7 |
| Molecular Weight | 218.25 |
| NACRES | NA.24 |
| PubChem Substance ID | 329820263 |
| UNSPSC Code | 41116107 |
| EC Number | 204-737-0 |
| MDL number | MFCD00038662 |
Safety Information Handling visibility
| pictograms |
GHS08
GHS07
  GHS08,GHS07
|
|---|---|
| signalword | Warning |
| hcodes | H302,H351,H361d |
| pcodes | P202 - P264 - P280 - P301 + P312 - P308 + P313 - P405 |
| Hazard Classifications | Acute Tox. 4 Oral - Carc. 2 - Repr. 2 |
| Storage Class | 11 - Combustible Solids |
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
| ppe | Eyeshields, Gloves, type P3 (EN 143) respirator cartridges |
Technical Overview & Applications Use-case context
Primidone, with the chemical formula C12H14N2O2 and CAS number 125-33-7, is an anticonvulsant medication primarily used in the treatment of epilepsy. It is a white, crystalline powder that is highly soluble in water and has a molecular weight of 218.25 g/mol. Primidone is metabolized in the liver to its active metabolites, phenobarbital and phenylethylmalonamide, which contribute to its therapeutic effects. The mechanism of action of primidone involves the modulation of neuronal excitability and the inhibition of synaptic transmission, resulting in a decrease in seizure frequency and severity. Primidone is often used in combination with other antiepileptic medications to achieve optimal therapeutic outcomes, and its dosage and administration are carefully tailored to individual patient needs to minimize adverse effects and maximize efficacy. Its pharmacokinetic properties and metabolic pathways have been extensively studied.
